3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Caprylates: new trials by email Literature Review of Caprylates trials Research Report on Caprylates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified, Albumin (Human) 25%, United States Pharmacopeia (USP) - Macular Degeneration | Phase 2 | Completed | Grifols Therapeutics LLC | 96 | 2004-01-01 | 2016-03-21 |
| Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified - Purpura, Thrombocytopenic, Idiopathic | Phase 2 | Completed | Grifols Therapeutics LLC | 8 | 2003-07-01 | 2016-04-27 |
| Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified, Albumin (Human) 25%, United States Pharmacopeia (USP) - Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Completed | Grifols Therapeutics LLC | 128 | 2002-12-01 | 2016-04-27 |
Macular Degeneration (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Purpura, Thrombocytopenic (1) · Purpura, Thrombocytopenic, Idiopathic (1)
Germany (2) · United States (2) · Austria (1) · Canada (1) · Czechia (1) · Greece (1) · Hungary (1) · Israel (1) · Poland (1) · Slovakia (1) · Sweden (1) · United Kingdom (1)
Fred D Lublin, MD (1) · James Bussel, MD (1) · Richard Brunner, MD (1)